Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NK1R antagonists(Neurokinin 1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H29F6N2O8P |
InChIKeyPKXQGSOAMISYFP-LJXNEXSDSA-N |
CAS Registry2573694-38-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Postoperative Nausea and Vomiting | Phase 2 | CN | 01 Jun 2024 | |
Vomiting | Phase 2 | CN | 01 Jun 2024 |